Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transurethral vaporization of the prostate: current techniques.

M A Cabelin1, A E Te, S A Kaplan

  • 1Department of Urology, The Prostate Center, The J. Bentley Squier Urological Clinic, New York-Presbyterian Hospital, Columbia Presbyterian Medical Center, 161 Fort Washington Avenue, 11th Floor, New York, NY 10032, USA.

Current Urology Reports
|June 27, 2002
PubMed
Summary

Electrovaporization is an effective treatment for benign prostatic hyperplasia, offering similar results to transurethral prostatectomy (TURP) with reduced complications. Newer techniques like vaporizing-resection show promise for larger prostates and improved outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of α- and β-adrenergic signaling in phenotypic targeting: significance in benign and malignant urologic disease.

Cell communication and signaling : CCS·2021
Same author

Efficacy and safety of fesoterodine 8 mg in subjects with overactive bladder after a suboptimal response to tolterodine ER.

International journal of clinical practice·2014
Same author

Management of benign prostatic hyperplasia: role of phosphodiesterase-5 inhibitors.

Drugs & aging·2014
Same author

PDE5-Is for the Treatment of Concomitant ED and LUTS/BPH.

Current bladder dysfunction reports·2013
Same author

Systematic review of the relationship between bladder and bowel function: implications for patient management.

International journal of clinical practice·2013
Same author

A 5-year retrospective analysis of 5α-reductase inhibitors in men with benign prostatic hyperplasia: finasteride has comparable urinary symptom efficacy and prostate volume reduction, but less sexual side effects and breast complications than dutasteride.

International journal of clinical practice·2012

Area of Science:

  • Urology
  • Minimally Invasive Surgery
  • Electrosurgery

Background:

  • Benign prostatic hyperplasia (BPH) is a common condition requiring effective treatment.
  • Transurethral prostatectomy (TURP) is a standard BPH treatment but has associated morbidity.
  • Electrovaporization has emerged as a popular alternative for BPH management.

Purpose of the Study:

  • To review the principles and advancements in electrovaporization techniques for BPH.
  • To compare the efficacy and morbidity of electrovaporization with TURP.
  • To discuss new technologies and clinical experiences with electrovaporization.

Main Methods:

  • Review of electrosurgical principles and electrode design.
  • Analysis of existing long-term data comparing electrovaporization and TURP.

Related Experiment Videos

  • Evaluation of pilot studies on vaporizing-resection and bipolar electrovaporization.

    • Main Results:

    • Electrovaporization effectively ablates prostatic tissue using vaporization and desiccation.
    • Vaporizing-resection offers efficient treatment for large prostates with minimized bleeding.
    • Bipolar electrovaporization represents a new technological advancement in BPH treatment.

    Conclusions:

    • Electrovaporization provides TURP-like efficacy with potentially lower morbidity.
    • Vaporizing-resection and bipolar electrovaporization show promising results for BPH treatment.
    • Continued research and clinical experience are vital for optimizing vaporization techniques.